Brainstorm Cell Therapeutics Inc. (BCLI): Price and Financial Metrics
BCLI Price/Volume Stats
| Current price | $2.28 | 52-week high | $11.89 |
| Prev. close | $2.08 | 52-week low | $1.05 |
| Day low | $2.20 | Volume | 197,800 |
| Day high | $2.45 | Avg. volume | 64,250 |
| 50-day MA | $1.70 | Dividend yield | N/A |
| 200-day MA | $4.89 | Market Cap | 13.00M |
BCLI Stock Price Chart Interactive Chart >
Brainstorm Cell Therapeutics Inc. (BCLI) Company Bio
Brainstorm Cell Therapeutics Inc., a biotechnology company, develops adult stem cell therapies for neurodegenerative disorders. The company was founded in 2000 and is based in Hackensack, New Jersey.
BCLI Price Returns
| 1-mo | 83.87% |
| 3-mo | -37.40% |
| 6-mo | -60.00% |
| 1-year | -23.08% |
| 3-year | -95.53% |
| 5-year | -96.03% |
| YTD | -44.32% |
| 2023 | -83.35% |
| 2022 | -59.00% |
| 2021 | -11.60% |
| 2020 | 5.72% |
| 2019 | 20.56% |
Loading social stream, please wait...